MedPath

AMGLIDIA 0,6 mg/ml SUSPENSION ORAL

AMGLIDIA 0,6 mg/ml SUSPENSION ORAL

Pending
Register Number

1181279001

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jan 14, 2021

Dosage Form

SUSPENSIÓN ORAL

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1181279001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

GLIBENCLAMIDAActive
Quantity: 18 mg
Name: GLIBENCLAMIDA

ATC CLASSIFICATION (3)

A10B
A10BB
A10BB01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.